Vetmab Biosciences, Inc.

Amendment
CIK: 0001932050·Biotechnology·DELAWARE·Filed: Dec 5, 2023
Total Offering

$5,000,000

Amount Sold

$575,000

Investors

5

First Sale

Nov 21, 2023

Offering Details

Type
Equity, Option to Acquire
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2022
Non-Accredited Investors
No

Related Persons

NameRole
Denise Bevers
Related Person
Richard Chin
Related Person
Hangjun Zhan
Related Person

Company

Vetmab Biosciences, Inc.

58 W. PORTAL AVE. #105

SAN FRANCISCO, CA, 94127

619-723-6476

SEC Filing

0001932050-23-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free